The global automated breast ultrasound system market will exhibit a volume CAGR of 11.1% during the forecast period (2018-2027), accor ding to a new analytical research study of Fact.MR. Ultrasound system market to reach nearly US $ 345 Mn in revenues by 2027-end.
ABUS gaining Competitive Edge over HHUS
Breast cancer has prevailed as the most commonly diagnosed cancer type, and has become the second leading cause of mortality amongst women, according to statistics from the National Breast Cancer Foundation. With growing awareness about cancer breast cancer, number of screening procedures has proliferated, as well as propelling demand for advanced diagnostic and follow-up care technologies. Facilitated screening of the breasts tissues, along with the provision of an automated ultrasound system (ABUS), has provided a competitive edge over the handheld ultrasound system (HHUS).
Request Sample Report with Table of Contents, Tables and Figures – https://www.factmr.com/connectus/sample?flag=S&rep_id=585
As automated breast ultrasound system are approved by the FDA for screening in coordination with mammography, in case of women with breast tissues, radiologists are increasingly opting for the technology. On the back of high quality 3D images offered by ABUS, surgeons are using the system for pre-operative breast evaluation to identify tumor size and location accurately. However, high cost, and a lot of skilled radiologists needed for ABUS have made surgeons to opt for HHUS for pre-operative evaluation.
Governments across the globe are launching awareness campaigns for encouraging women with breast cancer. Public Health England, for example, launches a campaign – ‚Be Clear on Cancer‘ in 2015 for breast cancer awareness among women over seventy years old. In addition, the Cancer Cancer Catalyst Program encourages and offers tremendous support to the diagnosis and treatment of breast cancer. Awareness campaigns on breast cancer are also expected.
Key Takeaways from Fact.MR’s Automated Breast Ultrasound System Market Report
1- North America wants to continue to account for the bulk of the ultrasound system market. North America, on account of growing breast cancer prevalence and adoption of advanced screening technologies. Presence of leading market participants, favorable government initiatives, and reimbursement scenarios are key growth determinants for automated ultrasound system market in North America.
To know more about Automated Breast Ultrasound System Market Trends, check the link – https://www.factmr.com/report/585/automated-breast-ultrasound-system-market
2 Asia-Pacific excluding Japan (APEJ) is estimated to be the fastest expanding market for automated breast ultrasound system through 2027. Revenues from the market in Europe will remain comparatively larger than Those from APEJ, and lower than Those from North America.
3- On the basis of care type, hospitals wants to continue to spearhead the ultrasound ultrasound system, in terms of revenues. However, CAGR through 2027.
Leading players in the global automated breast ultrasound system market have been following a strategic inorganic expansion roadmap. GE Healthcare, for instance, acquired U-Systems, Inc., for its portfolio of breast care innovations. Philips and SonoCine, Inc., entering a partnership for ABUS imaging. Key market players profiled by Fact.MR’s report are SonoCine Inc., Koninklijke Philips NV, Hitachi, Ltd., Siemens AG, Delphinus Medical Technologies, Inc., and GE Healthcare.
Inquire about this report – https://www.factmr.com/checkout/585/S
About Fact.MR
Fact.MR is a full-growing suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/